Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Transcenta and Agilent Collaborate on Companion Diagnostic for Claudin18.2 mAb

YS Biopharma Says PIKA Rabies Vaccine Effective after One-Week Dosing

Abbisko Completes Enrollment in Global Phase III Trial for Tenosynovial Giant Cell Tumor

Kelun/Merck Release Positive Early Data on TROP-2 ADC for Gastric Cancer

Kexing Biopharm’s Phase III Trial of Inhaled RSV Therapy for Children

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital